Financial reports
10-Q
2007 Q3
Quarterly report
13 Aug 07
10-Q
2007 Q2
Quarterly report
11 May 07
10-Q
2007 Q1
Quarterly report
13 Feb 07
ARS
2006 FY
Annual report to shareholders
13 Feb 07
10-K
2006 FY
Annual report
27 Dec 06
10-Q
2006 Q3
Quarterly report
11 Aug 06
10-Q
2006 Q2
Quarterly report
11 May 06
10-Q
2006 Q1
Quarterly report
14 Feb 06
10-K
2005 FY
Annual report
2 Dec 05
10-Q
2005 Q3
Quarterly report
12 Aug 05
Current reports
8-K
Inverness Medical Innovations, Inc. Extends Exchange Offer for 7.875% Senior Notes due 2016
25 May 10
8-K
HemoSense Receives Patent Infringement Notification from Beckman Coulter
22 Oct 07
8-K
Departure of Directors or Principal Officers
9 Oct 07
8-K
Entry into a Material Definitive Agreement
7 Aug 07
8-K
HemoSense Signs Definitive Agreement to be Acquired by Inverness
7 Aug 07
8-K
Results of Operations and Financial Condition
1 May 07
8-K
Other Events
21 Feb 07
8-K
Results of Operations and Financial Condition
1 Feb 07
8-K
Entry into a Material Definitive Agreement
1 Feb 07
8-K
Other Events
19 Dec 06
Registration and prospectus
424B3
Prospectus supplement
13 Dec 10
D
$400M in debt / Subsidiary Guarantees, sold $400M, 5 investors
6 Oct 10
424B3
Prospectus supplement
23 Apr 10
POSASR
Automatic shelf registration (post-effective amendment)
29 Mar 10
S-4
Registration of securities issued in business combination transactions
12 Feb 10
D
$100M in debt / Subsidiary Guarantees, sold $100M, 3 investors
13 Oct 09
Proxies
DEFA14A
Additional proxy soliciting materials
2 Oct 07
DEFA14A
Additional proxy soliciting materials
8 Aug 07
DEFA14A
Additional proxy soliciting materials
7 Aug 07
DEFA14A
Additional proxy soliciting materials
7 Aug 07
DEF 14A
Definitive proxy
29 Jan 07
DEFR14A
Revised proxy
10 Feb 06
DEF 14A
Definitive proxy
27 Jan 06
Other
EFFECT
Notice of effectiveness
10 Dec 10
UPLOAD
Letter from SEC
30 Nov 10
EFFECT
Notice of effectiveness
21 Apr 10
EFFECT
Notice of effectiveness
8 Nov 07
EFFECT
Notice of effectiveness
8 Nov 07
EFFECT
Notice of effectiveness
9 Mar 07
EFFECT
Notice of effectiveness
17 Oct 06
UPLOAD
Letter from SEC
28 Jun 05
UPLOAD
Letter from SEC
28 Jun 05
CORRESP
Correspondence with SEC
27 Jun 05